Minimed Group Inc <MMED.O>: UBS Raises Target Price to $28 from $25
MMED•Related News
Blackout risk rises as heat wave stresses largest US electric grids
XLU•
Purple Biotech says USPTO issues notice of allowance for CAPTN-3 tri-specific antibody patent application
PPBT•
TScan Therapeutics falls after pausing cancer trial
TCRX•
Uber To Cut 3,300 Jobs In Company Overhaul To Reduce Management Layers
UBER•
Edgewise Therapeutics grants inducement equity awards covering 31,501 shares to new hires
EWTX•